Fitusiran Curbs Bleeds in Hemophilia A, B With Inhibitors, Data Show

Fitusiran Curbs Bleeds in Hemophilia A, B With Inhibitors, Data Show

311960

Fitusiran Curbs Bleeds in Hemophilia A, B With Inhibitors, Data Show

When given monthly to people with hemophilia A or B with inhibitors, fitusiran significantly reduced bleeding, and for some, fully eliminated them, according to data from the Phase 3 ATLAS-INH study. In addition, data from other studies indicated that when used long-term, fitusiran was able to improve the quality of life of hemophilia A patients with or without inhibitors. These findings will be presented at the American Society of Hematology Annual Meeting, to be held…

You must be logged in to read/download the full post.